Comparative Effectiveness and Cost-Effectiveness of Three First-Line EGFR-tyrosine Kinase Inhibitors: Analysis of Real-World Data in a Tertiary Hospital in Taiwan

PLoS ONE- United States

doi 10.1371/journal.pone.0231413

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Cn8 - Cost-Effectiveness Analysis of Oral Cancer Screening in Taiwan: A Real World Data Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated With First-Line Tyrosine Kinase Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2016English

Ce4 - Cost-Effectiveness Analysis of First-Line Osimertinib in Patients With Egfr Mutation-Positive Non-Small Cell Lung Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Comparative Effectiveness Analysis of the Implementation of Surgical Safety Checklists in a Tertiary Care Hospital

JAMA Surgery
Surgery
2016English

P1.01-39 Cost-Effectiveness of Crizotinib Versus Chemotherapy as First-Line Treatment of ALK Positive Advanced NSCLC -- A Real World Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effectiveness and Cost-Effectiveness of Imatinib for First-Line Treatment of Chronic Myeloid Leukaemia in Chronic Phase: A Systematic Review and Economic Analysis

Health Technology Assessment
MedicineHealth Policy
2004English

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Co1 Comparative Effectiveness Analysis of TNF Blockers in Rheumatoid Arthritis (Ra) Patients in a Real-World Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Cost-Effectiveness of Xpert MTB/RIF for Tuberculosis Diagnosis in South Africa: A Real-World Cost Analysis and Economic Evaluation

Indian Journal of Tuberculosis
Infectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy